ReviewCurrent cardiology reports2025
Psychological Aspects of Wearable Health Technologies in Patients with Cardiovascular Disease: A Literature Review and Call to Action.
Review in Current cardiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purpose of reviewThis review summarizes the psychological effects of consumer wearables in patients with established cardiovascular disease (CVD) and helps to identify remaining challenges that must be resolved to support the appropriate implementation of wearables. RECENT
findingsConsumer wearables (e.g., smartwatches, portable rhythm devices, rings, fitness bands, skin-surface patches) are increasingly used "off label" by patients and healthcare providers for ambulatory CVD monitoring and lifestyle modification. Emerging research suggests that while these technologies can motivate some patients to engage in healthy behaviors, they can also provoke adverse psychological reactions in others. Additionally, there are unintended, downstream consequences for clinicians and healthcare systems. Wearables show great promise for enhancing CVD management by providing patients and clinicians with continuous data on key health metrics that can be used for diagnostic and therapeutic purposes. Yet, the potential risks associated with their use must be acknowledged, rigorously investigated, and appropriately managed. Findings from this review emphasize the need for large, well-designed prospective studies and randomized trials to evaluate a broad range of wearable technologies and their influence on patients' mental health, quality of life, and CVD self-management over longer time periods and in high-risk groups (e.g., women, minorities, and children), and to determine their impact on patient outcomes, provider burden, healthcare utilization and costs. Addressing these challenges is crucial for fully integrating wearable health technologies into clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.